Exane Derivatives’s Tilray TLRY Stock Holding History

Exane Derivatives’s Portfolio TLRY Stock Details TLRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3	Closed	-$7.98K	–	717
2019 Q1	$7.98K	Buy	+3	New	+$2.29K	﹤0.01%	402

Other funds holding TLRY

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Exane Derivatives's TLRY Position: Q2 2022 in Review

Exane Derivatives sold out of Tilray (TLRY) in Q2 2022, closing a stake of 307 shares — an estimated $23.9K sold.

Exane Derivatives first reported a position in TLRY in Q3 2018 and held it in 14 quarters. The position peaked at $780K in Q2 2019. 354 funds tracked by Wall St. Rank hold TLRY as of Q2 2022.

Exane Derivatives reported no remaining Tilray position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 307 Tilray shares in Q2 2022, an estimated $23.9K.
Exane Derivatives first reported a position in Tilray in Q3 2018 and held it in 14 quarters.
Exane Derivatives's Tilray position peaked at $780K in Q2 2019.
354 funds tracked by Wall St. Rank held Tilray as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.